Search results for " serum"

showing 10 items of 377 documents

Chronic graft-versus-host disease: long-term results from a randomized trial on graft-versus-host disease prophylaxis with or without anti-T-cell glo…

2011

Abstract Previous randomized graft-versus-host disease (GVHD)-prophylaxis trials have failed to demonstrate reduced incidence and severity of chronic GVHD (cGVHD). Here we reanalyzed and updated a randomized phase 3 trial comparing standard GVHD prophylaxis with or without pretransplantation ATG-Fresenius (ATG-F) in 201 adult patients receiving myeloablative conditioning before transplantation from unrelated donors. The cumulative incidence of extensive cGVHD after 3 years was 12.2% in the ATG-F group versus 45.0% in the control group (P < .0001). The 3-year cumulative incidence of relapse and of nonrelapse mortality was 32.6% and 19.4% in the ATG-F group and 28.2% and 33.5% in the contr…

AdultMalemedicine.medical_specialtyTime FactorsTransplantation ConditioningAdolescentmedicine.medical_treatmentImmunologyMedizinGraft vs Host DiseaseHematopoietic stem cell transplantationBiochemistryGastroenterologyDisease-Free Survivallaw.inventionRandomized controlled triallawRecurrenceInternal medicinemedicineHumansTransplantation HomologousCumulative incidenceSurvival rateAntilymphocyte SerumImmunosuppression Therapybusiness.industryIncidence (epidemiology)Hazard ratioHematopoietic Stem Cell TransplantationCell BiologyHematologyMiddle Agedmedicine.diseaseSurgeryTransplantationSurvival RateGraft-versus-host diseaseMethotrexateHematologic NeoplasmsChronic DiseaseCyclosporineFemalebusinessImmunosuppressive AgentsBlood
researchProduct

Standard graft-versus-host disease prophylaxis with or without anti-T-cell globulin in haematopoietic cell transplantation from matched unrelated don…

2009

Graft-versus-host disease (GVHD) is a major cause of morbidity and mortality after allogeneic haematopoietic cell transplantation from unrelated donors. Anti-T-cell globulins (ATGs) might lower the incidence of GVHD. We did a prospective, randomised, multicentre, open-label, phase 3 trial to compare standard GVHD prophylaxis with ciclosporin and methotrexate with or without anti-Jurkat ATG-Fresenius (ATG-F).Between May 26, 2003, and Feb 8, 2007, 202 patients with haematological malignancies were centrally randomly assigned using computer-generated centre-stratified block randomisation between treatment groups receiving ciclosporin and methotrexate with or without additional ATG-F. One patie…

AdultMalemedicine.medical_specialtyTransplantation ConditioningAdolescentmedicine.medical_treatmentT-LymphocytesGraft vs Host DiseaseHematopoietic stem cell transplantationGastroenterologyInternal medicinemedicineHumansTransplantation HomologousCumulative incidenceProspective StudiesAntilymphocyte Serumbusiness.industryHazard ratioHematopoietic Stem Cell TransplantationMiddle AgedCiclosporinmedicine.diseaseSurvival AnalysisAnti-thymocyte globulinSurgeryTransplantationGraft-versus-host diseaseMethotrexateOncologyHematologic NeoplasmsCyclosporineRegression AnalysisDrug Therapy CombinationFemaleTransplantation ConditioningbusinessImmunosuppressive Agentsmedicine.drugThe Lancet. Oncology
researchProduct

Rabbit anti-thymocyte globulin in liver transplantation: All that glitters is not gold, but 1000 patients are so many to dazzle

2012

AdultPathologymedicine.medical_specialtyBiopsymedicine.medical_treatmentLiver transplantationEnd Stage Liver DiseaseRecurrenceBiopsyAnimalsHumansMedicineAntilymphocyte SerumClinical Trials as TopicTransplantationHepatologymedicine.diagnostic_testbusiness.industryCase-control studyEnd stage liver diseaseHepatitis CMiddle Agedmedicine.diseaseHepatitis CLiver TransplantationAnti-thymocyte globulinCase-Control StudiesImmunologySurgeryRabbitsbusinessImmunosuppressive AgentsLiver Transplantation
researchProduct

Atmospheric protein chemistry influenced by anthropogenic air pollutants: nitration and oligomerization upon exposure to ozone and nitrogen dioxide

2017

The allergenic potential of airborne proteins may be enhanced via post-translational modification induced by air pollutants like ozone (O3) and nitrogen dioxide (NO2). The molecular mechanisms and kinetics of the chemical modifications that enhance the allergenicity of proteins, however, are still not fully understood. Here, protein tyrosine nitration and oligomerization upon simultaneous exposure of O3 and NO2 were studied in coated-wall flow-tube and bulk solution experiments under varying atmospherically relevant conditions (5–200 ppb O3, 5–200 ppb NO2, 45–96% RH), using bovine serum albumin as a model protein. Generally, more tyrosine residues were found to react via the nitration pathw…

Air PollutantsOzone010504 meteorology & atmospheric sciencesbiologyAtmosphereNitrogen DioxideKineticsProteins010501 environmental sciences01 natural sciencesOligomerchemistry.chemical_compoundOzonechemistryNitrationEnvironmental chemistrybiology.proteinProtein oligomerizationNitrogen dioxideTropospheric ozonePhysical and Theoretical ChemistryBovine serum albumin0105 earth and related environmental sciencesFaraday Discussions
researchProduct

Higher serum levels of periostin and the risk of exacerbations in moderate asthmatics

2016

BACKGROUND: In asthma, exacerbations and poor disease control are linked to airway allergic inflammation. Serum periostin has been proposed as a systemic biomarker of eosinophilic inflammation. This pilot study aims at evaluating whether in patients with moderate asthma, higher baseline levels of serum periostin are associated with a greater risk of exacerbation. METHODS: Fifteen outpatients with moderate allergic asthma were recruited. Serum concentrations of periostin were assessed (ELISA) at baseline, and the frequency of asthma exacerbations was recorded during a one-year follow-up. RESULTS: Patients (M/F: 10/5, mean age of 47.6 ± 11.0 years) had mean ACQ score of 5.5 ± 4.2 and FEV1%pre…

Allergymedicine.medical_specialtyExacerbationSerum biomarkerPeriostinSettore MED/10 - Malattie Dell'Apparato RespiratorioBiochemistryAllergic inflammation03 medical and health sciences0302 clinical medicineInternal medicinemedicineAsthmatic patient030212 general & internal medicineAirway inflammation; Asthma; Exacerbation; Periostin; Serum biomarkerAsthmabusiness.industryResearchOrganic ChemistryExacerbationmedicine.diseaseSerum biomarker Asthma Periostin Exacerbation Airway inflammationAsthmaPeriostin030228 respiratory systemImmunologyBiomarker (medicine)businessAirwayAirway inflammation
researchProduct

The EAACI/GA2LEN/EDF/WAO Guideline for the definition, classification, diagnosis, and management of urticaria: the 2013 revision and update

2014

This guideline is the result of a systematic literature review using the 'Grading of Recommendations Assessment, Development and Evaluation' (GRADE) methodology and a structured consensus conference held on 28 and 29 November 2012, in Berlin. It is a joint initiative of the Dermatology Section of the European Academy of Allergy and Clinical Immunology (EAACI), the EU-funded network of excellence, the Global Allergy and Asthma European Network (GA(2)LEN), the European Dermatology Forum (EDF), and the World Allergy Organization (WAO) with the participation of delegates of 21 national and international societies. Urticaria is a frequent, mast cell-driven disease, presenting with wheals, angioe…

Allergymedicine.medical_specialtyhivesImmunologylcsh:Medicine610 Medicine & healthDermatologyDiseaseurticariaimmune system diseaseslcsh:DermatologyHumansImmunology and AllergyMedicinemedia_common.cataloged_instanceEuropean unionskin and connective tissue diseaseswhealAsthmamedia_common2403 ImmunologyAcute urticariaAngioedemabusiness.industryangioedemalcsh:RConsensus conferenceangioedema; consensus; hives; urticaria; wheal; Humans; Urticaria10177 Dermatology ClinicGuidelinelcsh:RL1-803angioedema consensus hives urticaria wheal CHRONIC IDIOPATHIC URTICARIA QUALITY-OF-LIFE SERUM SKIN-TEST DELAYED PRESSURE URTICARIA DOSE INTRAVENOUS IMMUNOGLOBULIN ANTIIMMUNOGLOBULIN-E THERAPY RESISTANT CHRONIC URTICARIA RANDOMIZED CONTROLLED-TRIAL ULTRAVIOLET-B PHOTOTHERAPY WORLD-HEALTH-ORGANIZATIONmedicine.diseaseDermatologySystematic reviewconsensusFamily medicine2723 Immunology and Allergymedicine.symptombusinessAllergy
researchProduct

Ready Access to Proquinazid Haptens via Cross-Coupling Chemistry for Antibody Generation and Immunoassay Development.

2015

17 pages, 4 tables, 5 figures.-- Publisher's PDF

AnalyteAryl halideSonogashira couplinglcsh:MedicineAntibody productionAntibodieschemistry.chemical_compoundmedicineImmune serumAnimalsBovine serum albuminEnzyme-linked immunoassaysImmunoassayslcsh:ScienceGeneralLiterature_REFERENCE(e.g.dictionariesencyclopediasglossaries)Quinazolinoneschemistry.chemical_classificationImmunoassayMultidisciplinaryBioconjugationmedicine.diagnostic_testbiologyiodineAryllcsh:RSerum Albumin BovineCombinatorial chemistrychemistryImmunoassaybiology.proteinComputingMethodologies_DOCUMENTANDTEXTPROCESSINGCattlelcsh:QRabbitsHaptenHaptensResearch ArticlePLoS ONE
researchProduct

Multivariate optimization approach for chiral resolution of drugs using human serum albumin in affinity electrokinetic chromatography-partial filling…

2005

The enantiomeric resolution of chiral compounds using HSA by means of affinity EKC (AEKC)-partial filling technique is the result of a delicate balance between different experimental variables such as protein concentration, running pH (background electrophoretic buffer, protein and compound solutions) and protein solution plug length. In this paper multivariate optimization approaches for chiral separation of four basic drugs (alprenolol, oxprenolol, promethazine and propranolol) using HSA as chiral selector in AEKC-partial filling technique are studied. The experimental conditions to achieve maximum resolution are optimized using the Box-Behnken experimental design. Partial least squares a…

AnalyteResolution (mass spectrometry)Clinical BiochemistryAnalytical chemistryBiochemistryPromethazineChromatography AffinityAnalytical ChemistryElectrokinetic phenomenaPartial least squares regressionmedicineHumansAminesAlprenololSerum AlbuminChromatographyChemistryElectrophoresis CapillaryOxprenololStereoisomerismHuman serum albuminPropranololChiral resolutionElectrophoresisPharmaceutical PreparationsMultivariate AnalysisEnantiomerHydrophobic and Hydrophilic Interactionsmedicine.drugElectrophoresis
researchProduct

Carbon nanotube-protein carriers enhance size-dependent self-adjuvant antibody response to haptens

2013

Carbon nanotubes (CNTs) are nanomaterials with interesting emerging applications. Their properties make CNTs excellent candidates for use as new nanovehicles in drug delivery, immunization and diagnostics. In the current study, we assessed the immune-response-amplifying properties of CNTs to haptens by using azoxystrobin, the first developed strobilurin fungicide, asamodel analyte. Anazoxystrobin derivative bearingacarboxylated spacer arm (hapten AZc6) was covalently coupled to bovine serum albumin (BSA), and the resulting BSA-AZc6 conjugate was covalently linked to four functionalized CNTs of different shapes and sizes, varying in diameter and length. These four types of CNT-based construc…

Analytemedicine.medical_treatmentAzoxystrobinFreund's AdjuvantAntigen deliveryCarbon nanotubesPharmaceutical ScienceAntibodiesBiomaterialsMicechemistry.chemical_compoundMicroscopy Electron TransmissionmedicineAnimalsOrganic chemistryBovine serum albuminDrug CarriersMice Inbred BALB CbiologyNanotubes CarbonChemistrySerum Albumin BovineStrobilurinsFungicides IndustrialPyrimidinesAzoxystrobinImmunoglobulin GDrug deliverybiology.proteinBiophysicsMethacrylatesFemaleImmunizationRabbitsAntibodyHaptensAdjuvantHaptenConjugate
researchProduct

Autologous conditioned serum for chronic pain in patients with osteoarthritis: A feasibility observational study

2022

Background Autologous conditioned serum is a product of blood origin, with fragmented evidence of therapeutic properties in osteoarthritis chronic pain. This pilot observational prospective study aimed to evaluate the feasibility of a treatment with conditional autologous serum (ACS) in patients with severe chronic pain and grade I-III osteoarthritis and to describe its cytokine content. Methods We prospectively collected data on consecutive patients affected by osteoarthritis grade I to III and treated with four weekly injections of ACS at our outpatient pain service. The primary outcome was pain intensity, measured with the visual analogic scale (VAS). Additional outcomes were symptoms ev…

Anesthesiology and Pain Medicineosteoarthritis autologous conditioned serum visual analogic scale short form health survey-36
researchProduct